Osteal Macrophages: Novel Regulators Of Osteoblast Function And The Endosteal Stem Cell Niche
Funder
National Health and Medical Research Council
Funding Amount
$406,125.00
Summary
Bone diseases are a major health problem and current treatments are inadequate. We are investigating a novel role for macrophages (cells important in tissue maintenance and immune responses) in bone growth, repair and disease. Greater understanding of this will provide new ways to treat bone disease. We will also determine if these macrophages help support stem cells that reside near bone surfaces, which may provide new treatment strategies to improve bone marrow transplantation in cancer.
New Insights Into The Mechanisms Of Thrombogenesis In Atrial Fibrillation
Funder
National Health and Medical Research Council
Funding Amount
$443,946.00
Summary
Atrial fibrillation (AF) is the most common heart rhythm disturbance (arrhythmia), which is associated with a high risk of stroke due to clot formation within the left atria. At present we still only have a limited understanding of the mechanism of clot formation in AF. The aim of this study is to determine the critical mechanisms that contribute to clot formation within the left atria in AF. This knowledge is fundamental to the development of more successful interventional approaches.
Wounds, burns and scalds are frequent injuries which can lead to deformity, disfigurement and loss of movement. We have shown that the cytoskeletal protein, Flightless I (FliI), is an important regulator of wound repair. We plan to further investigate FliI in wound and burn injuries using new cell-specific transgenic animal models and to develop a new FliI-antibody based therapy to treat wound and burn injuries.
Acute Lymphoblastic Leukemia And The Bone Marrow Microenvironment
Funder
National Health and Medical Research Council
Funding Amount
$420,872.00
Summary
This research aims to identify new drugs for the treatment of childhood and adult acute lymphoblastic leukemia (ALL). We have identified drugs that interfere with interactions between the bone marrow and leukemic cells and hypothesise that these will increase the potency of currently used chemotherapy. We will test these agents in animal models of human leukemia. By analysing the effects of these new drugs we will also understand how we can further improve treatments.
Characterisation And Therapeutic Targeting Of Molecular Pathways That Promote Breast Cancer Metastasis To Bone
Funder
National Health and Medical Research Council
Funding Amount
$442,573.00
Summary
Breast cancer that has spread to bone cannot be cured. Using the most clinically relevant model of breast cancer available we have identified that tumour cells growing in bone need to suppress immune elimination (by suppressing the Type I interferons) and invade through the bone tissue (by activation of cysteine cathepsins). Studying the functional role of these pathways will provide novel insight into the mechanisms of breast cancer spread to bone that can be augmented therapeutically.
Psychiatric Disorders, Psychotropic Agents And Bone Health: From Benchtop To Bedside.
Funder
National Health and Medical Research Council
Funding Amount
$447,744.00
Summary
Just under half of all people with a psychiatric disorder have a chronic physical illness. One common and neglected comorbidity is osteoporosis. Dr Williams has brought together a multi-disciplinary team of researchers and clinicians that are gathering laboratory through to clinical evidence regarding the interplay between psychiatric disorders, the medication used to treat these disorders and bone health with the aim of informing clinical practice and guiding clinical choice.
New Approaches To The Prevention And Treatment Of Musculoskeletal Disease
Funder
National Health and Medical Research Council
Funding Amount
$466,492.00
Summary
In Australia, musculoskeletal conditions like osteoarthritis and back pain are responsible for much pain and disability. Although until recently these were considered to be purely due to wear and tear, Associate Professor Wluka, a rheumatologist, has shown that these are not simply due to overuse and loading but metabolic factors also play a role. This award will enable the role of these factors to be examined and new therapies tested in clinical trials, providing evidence to improve the managem ....In Australia, musculoskeletal conditions like osteoarthritis and back pain are responsible for much pain and disability. Although until recently these were considered to be purely due to wear and tear, Associate Professor Wluka, a rheumatologist, has shown that these are not simply due to overuse and loading but metabolic factors also play a role. This award will enable the role of these factors to be examined and new therapies tested in clinical trials, providing evidence to improve the management of these conditions.Read moreRead less
Manipulation Of Haematopoietic Stem Cell Niches To Improve Therapeutic Outcomes
Funder
National Health and Medical Research Council
Funding Amount
$451,716.00
Summary
My aim is to understand how stem cells are naturally regulated by the body. My central hypothesis is that local environment (niche) factors largely govern stem cell behaviour. Identification and manipulation of these factors will offer a novel therapeutic opportunity to improve the clinical use of normal haematopoietic stem cells to improve transplantation success, as well as sensitise leukaemia cells to chemotherapy.